Go to
current issue
加入关注
本刊介绍/投稿指南
催更
样式： 排序： IF: - GO 导出 标记为已读
-
Warfarin is associated with higher rates of upper but not lower gastrointestinal bleeding compared to direct oral anticoagulants: a population-based propensity-weighted cohort study Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-14 Arnar B. Ingason, Johann P. Hreinsson, Arnar S. Agustsson, Sigrun H. Lund, Edward Rumba, Daniel A. Palsson, Indridi E. Reynisson, Brynja R. Gudmundsdottir, Pall T. Onundarson, Einar S. Bjornsson
Background and aims While overall gastrointestinal bleeding (GIB) rates have been extensively compared between warfarin and direct oral anticoagulants (DOACs), it is still unclear whether upper and lower GIB rates differ between these types of drugs. This study aimed to compare upper and lower GIB rates between warfarin and DOACs in a nationwide cohort. Methods Data on all patients in Iceland who received
-
-
Risk factors for early-onset colorectal cancer: further confirmation is needed Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-11 Jiayu Du, Yahao Lai, Li Zhang
Abstract not available
-
Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C) Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-11 Hongda Chen, Jufang Shi, Ming Lu, Yanjie Li, Lingbin Du, Xianzhen Liao, Donghua Wei, Dong Dong, Yi Gao, Chen Zhu, Rongbiao Ying, Weifang Zheng, Shipeng Yan, Haifan Xiao, Juan Zhang, Yunxin Kong, Furong Li, Shuangmei Zou, Min Dai
-
The Prevalence, Humanistic Burden, and Healthcare Impact of Irritable Bowel Syndrome (IBS) Among United States Veterans Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-11 Andrea Shin, Huiping Xu, Thomas F. Imperiale
-
PSYCHOTHERAPY FOR ALCOHOL USE DISORDER IS ASSOCIATED WITH REDUCED RISK OF INCIDENT ALCOHOL-ASSOCIATED LIVER DISEASE Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-11 Augustin G.L. Vannier, Eric M. Przybyszewski, Jessica Shay, Suraj J. Patel, Esperance Schaefer, Russell P. Goodman, Jay Luther
Background and Aims Alcohol-associated liver disease (ALD) is a devastating complication of alcohol use disorder (AUD). Once it develops, ALD is exceedingly difficult to treat; it is therefore critical to identify ways to prevent ALD. By treating the causes of elevated alcohol consumption, psychotherapy may offer prophylactic benefit against the development of ALD for patients with AUD. Methods In
-
Letter to the Editor: Waist Circumference and Insulin Resistance Are the Most Predictive Metabolic Factors for Steatosis and Fibrosis Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-11 Rui Wang, Yonghua Chen
Abstract not available
-
Reply: Does Fatty Liver Play a Role in the Risk of All-Cause and Cause-Specific Mortality in Patients with Gallstone Disease? Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-11 Donghee Kim, Peter Konyn, Aijaz Ahmed
Abstract not available
-
Skeletal muscle-derived cell implantation for the treatment of faecal incontinence: a randomized, placebo-controlled study Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-10 Andrea Frudinger, Annett Gauruder-Burmester, Wilhelm Graf, Jan-Peter Lehmann, Ulf Gunnarsson, Minko Mihov, Peter Ihnát, Pavle Kosorok, Julius Orhalmi, Petr Slauf, Anton Emmanuel, Vladislav Hristov, Anna Jungwirthova, Paul-Antoine Lehur, Andreas Müller, Melanie Amort, Rainer Marksteiner, Marco Thurner
Background and Aims Faecal incontinence (FI) improvement following injection of autologous skeletal muscle-derived cells has been previously suggested. This study aimed to test the efficacy and safety of said cells through a multi-center, placebo-controlled study, to determine an appropriate cell dose, and to delineate the target patient population that can most benefit from cell therapy. Methods Patients
-
Estimating the global burden of Epstein-Barr virus associated gastric cancer: a systematic review and meta-analysis Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-10 Mayo Hirabayashi, Damien Georges, Gary M. Clifford, Catherine de Martel
Background & aims Evidence suggests a fraction of new gastric cancer cases may be etiologically associated with Epstein-Barr virus (EBV), a known carcinogenic agent. We aimed to systematically explore the proportion of EBV-positive gastric cancer. Methods We did a systematic review (PROSPERO CRD42020164473) from January 1990 to August 2021. For each country and geographical region with available data
-
Comparative effectiveness research to position therapies in ulcerative colitis: how fair are the comparisons? Authors’ reply. Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-10 T. Straatmijer, A.E. van der Meulen, M. Duijvestein
Abstract not available
-
Management of Adults with Esophageal atresia Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-09 Julie Khlevner, Daniela Jodorkovsky, Dominique D. Bailey, William Middlesworth, Amrita Sethi, Julian Abrams, David A. Katzka
Esophageal atresia with or without trachea-esophageal fistula is relatively common congenital malformation with most patients living into adulthood. As a result, care of the adult EA patient is becoming more common. Although surgical repair has changed EA from a fatal to a livable condition, the residual effects of the anomaly may lead to a lifetime of complications. These include effects related to
-
UK-Wide Multicentre Evaluation of Second Line Therapies in Primary Biliary Cholangitis Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-09 Nadir Abbas, Emma L. Culver, Douglas Thorburn, Neil Halliday, Hannah Crothers, Jessica K. Dyson, April Phaw, Richard Aspinall, Salim I. Khakoo, Yiannis Kallis, Belinda Smith, Imran Patanwala, Anne McCune, Chenchu R. Chimakurthi, Vinod Hegade, Michael Orrell, Rebecca Jones, George Mells, Palak J. Trivedi.
-
Current Controversies and Challenges in Endoscopic Management of Necrotizing Pancreatitis Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-08 Guru Trikudanathan, Surinder S. Rana
Abstract not available
-
High Perceived Stress is Associated with Increased Risk of Ulcerative Colitis Clinical Flares Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-08 Jenny S. Sauk, Hyo Jin Ryu, Jennifer S. Labus, Ariela Khandadash, Aaron I. Ahdoot, Venu Lagishetty, William Katzka, Hao Wang, Bruce Naliboff, Jonathan P. Jacobs, Emeran A. Mayer
-
How to Promote Professional Identity Development and Support Fellows-In-Training Through Teaching, Coaching, Mentorship, and Sponsorship Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-07 Indira Bhavsar-Burke, Christen K. Dilly, Amy S. Oxentenko
Abstract not available
-
Long-term survival after endoscopic resection for gastric cancer: Real-world evidence from a multicenter prospective cohort Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-07 Haruhisa Suzuki, Hiroyuki Ono, Toshiaki Hirasawa, Yoji Takeuchi, Kenji Ishido, Shu Hoteya, Tomonori Yano, Shinji Tanaka, Yosuke Toya, Masahiro Nakagawa, Takashi Toyonaga, Kenichi Takemura, Kingo Hirasawa, Mitsuru Matsuda, Hironori Yamamoto, Yosuke Tsuji, Satoru Hashimoto, Maeda Yuki, Ichiro Oda
-
GENETIC DIAGNOSIS GUIDES TREATMENT OF AUTOIMMUNE ENTEROPATHY Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-06 Fabienne Charbit-Henrion, Manon Haas, Stanislas Chaussade, Christophe Cellier, Nadine Cerf-Bensussan, Georgia Malamut, Sherine Khater, Anis Khiat, Sascha Cording, Marianna Parlato, Marie-Agnès Dragon-Durey, Frédéric Beuvon, Nicole Brousse, Benoît Terris, Capucine Picard, Mathieu Fusaro, Frédéric Rieux-Laucat, Luc Mouthon
Abstract not available
-
The role of Over-the-scope clip in the management of non-variceal upper gastrointestinal bleeding Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-06 Fnu Chesta, Navtej S. Buttar
Abstract not available
-
Recent decline in the incidence of hepatocellular carcinoma in the United States Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-06 Aaron P. Thrift, Kyle S. Liu, Syed Ahsan Raza, Hashem B. El-Serag
Abstract not available
-
Risk of variceal bleeding in patients with advanced hepatocellular carcinoma receiving atezolizumab/bevacizumab Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-06 Yeonjung Ha, Jee Hyun Kim, Jaekyung Cheon, Gyeong Sik Jeon, Chan Kim, Hong Jae Chon
Abstract not available
-
Comparative Risk of Serious Infections with Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-06 Virginia Solitano, Antonio Facciorusso, Tine Jess, Christopher Ma, Cesare Hassan, Alessandro Repici, Vipul Jairath, Alessandro Armuzzi, Siddharth Singh
-
The COVID-19 Pandemic and Postinfection Irritable Bowel Syndrome: What Lies Ahead for Gastroenterologists Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-06 Walter W. Chan, Madhusudan Grover
Abstract not available
-
Cost-effectiveness of earlier or more intensive colorectal cancer screening in overweight and obese patients Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-05 Aaron Yeoh, Ajitha Mannalithara, Uri Ladabaum
-
Hepatocellular Carcinoma Incidence in Alcohol-associated Cirrhosis: Systematic Review and Meta-analysis Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-05 Daniel Q. Huang, Darren J.H. Tan, Cheng Han Ng, Maral Amangurbanova, Nancy Sutter, Phoebe Wen Lin Tay, Wen Hui Lim, Jie Ning Yong, Ansel Tang, Nicholas Syn, Mark D. Muthiah, Eunice X.X. Tan, Shravan Dave, Benjamin Tay, Abdul M. Majzoub, Danielle Gerberi, Beom Kyung Kim, Rohit Loomba
-
Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-04 Parambir S. Dulai, Brian G. Feagan, Bruce E. Sands, Jingjing Chen, Karen Lasch, Richard A. Lirio
Background & Aims We evaluated the value of post-induction fecal calprotectin (FCP) concentration as a biomarker in patients with ulcerative colitis (UC) treated with a biologic. Methods This post hoc analysis of the GEMINI 1/GEMINI LTS (N = 620) and VARSITY (N = 771) trials evaluated the cross-sectional accuracy of post-induction FCP in identifying endoscopic activity and histologic inflammation,
-
Empiric Pelvic Rehabilitation Delivered by Pelvic Floor Physical Therapists as an Up-Front Treatment for Chronic Constipation Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-04 Eric D. Shah, Michael A. Curley, Tracy L. Ostler, Aimee R. Burnett Greeley, Pablo Martinez-Camblor, William D. Chey
Abstract not available
-
Racial, Ethnic, and Socioeconomic Disparities in Treatment Delay among Patients with Hepatocellular Carcinoma in the United States Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-04 Nikita Sandeep Wagle, Sulki Park, David Washburn, Robert L. Ohsfeldt, Nicole E. Rich, Amit G. Singal, Hye-Chung Kum
Background Failures have been reported across the cancer care continuum in patients with hepatocellular carcinoma (HCC); however, the impact of treatment delays on outcomes has not been well characterized. We described the prevalence of treatment delays in a racially and ethnically diverse cohort of patients and its association with overall survival. Methods Using the Surveillance, Epidemiology, and
-
Disease state transition probabilities across the spectrum of NAFLD: A systematic review and meta-analysis of paired biopsy or imaging studies Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-04 Phuc Le, Julia Yang Payne, Lu Zhang, Abhishek Deshpande, Michael B. Rothberg, Naim Alkhouri, William Herman, Adrian V. Hernandez, Mary Schleicher, Wen Ye, Srinivasan Dasarathy
-
Safety and sustained efficacy of the farnesoid X receptor (FXR) agonist cilofexor over a 96-week open-label extension in patients with PSC Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-04 Michael Trauner, Christopher L. Bowlus, Aliya Gulamhusein, Bilal Hameed, Stephen H. Caldwell, Mitchell L. Shiffman, Charles Landis, Andrew J. Muir, Andrew Billin, Jun Xu, Xiangyu Liu, Xiaomin Lu, Chuhan Chung, Robert P. Myers, Kris V. Kowdley
Background and Aims Primary sclerosing cholangitis (PSC) is a major unmet medical need in clinical hepatology. Cilofexor is a non-steroidal FXR agonist being evaluated for the treatment of PSC. Here, we describe the safety and preliminary efficacy of cilofexor in a 96-week, open-label extension (OLE) of a phase 2 trial. Methods Non-cirrhotic subjects with large duct PSC who completed the 12-week, blinded
-
Intrahepatic splenosis: Benign but can be misdiagnosed Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-04 Rajanshu Verma, Vamsee Mupparaju, Satheesh P. Nair
Abstract not available
-
Removal of Giant Choledocholithiasis by Direct Cholangioscopy with Gastroscope and Electrohydraulic Lithotripsy Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-04 Brian M. Fung, Teodor C. Pitea
Abstract not available
-
Neighborhood-level factors contribute to disparities in hepatocellular carcinoma incidence in Texas. Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-04 Abiodun O. Oluyomi, Hashem B. El-Serag, Adegboyega Olayode, Aaron P. Thrift
-
Appendectomy and future risk of microscopic colitis: correlation or causation? Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-04 Cong Dai, Min Jiang, Yu-Hong Huang
Abstract not available
-
Association of Statin Usage and the Development of Diabetes Mellitus after Acute Pancreatitis Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-04 Liling Deng, Wuquan Deng
Abstract not available
-
Geographic Density of Gastroenterologists is Associated with Decreased Mortality from Alcohol-Associated Liver Disease Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-04 Brian P. Lee, Jennifer L. Dodge, Norah A. Terrault
Background&Aims Alcohol-associated liver disease (ALD) is the leading cause of liver-related mortality, and has been increasing. To inform public health efforts to addressing the growing incidence of ALD, we assessed the association of geographic density of gastroenterologists with ALD-related mortality. Methods National data was obtained for adults aged≥25, with state-level demographics and 2010-2019
-
Driving Quality in Advanced Endoscopy Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-02 Adarsh M. Thaker, Jennifer Phan, Phillip Ge, V. Raman Muthusamy
Abstract not available
-
Improving and Driving Efficiency in Your Endoscopy Unit in the 21st Century Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-08-01 Sumeet K. Tewani, George C. Tannous, Matthew W. Stier, Erica Natal, Joseph Vicari
Abstract not available
-
Promoting the Pipeline of Diverse Individuals Within Gastroenterology: Reflections From AGA FORWARD Program Scholars Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-22 Patricia D. Jones, Dominique D. Bailey, Oriana M. Damas, Veroushka Ballester, Eric Vargas, Antonio Mendoza-Ladd
Abstract not available
-
Contemporary changes in etiology for hepatocellular carcinoma in liver transplantation Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-20 Cameron Goff, Anjiya Shaikh, Karthik Goli, Hashem B. El-Serag, Fasiha Kanwal, George Cholankeril
Abstract not available
-
-
Editorial Board Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-22
Abstract not available
-
Table of Contents Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-22
Abstract not available
-
Elsewhere in the AGA Journals Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-22
Abstract not available
-
Blue Notes Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-22 Charles J. Kahi
Abstract not available
-
Exam 1: Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-22
Abstract not available
-
Paternal Medications in Inflammatory Bowel Disease and Male Fertility and Reproductive Outcomes: A Systematic Review and Meta-Analysis Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-20 John Gubatan, Grant E. Barber, Ole Haagen Nielsen, Carsten Bogh Juhl, Cynthia Maxwell, Michael L. Eisenberg, Sarah E. Streett
Background Studies evaluating reproductive outcomes among male patients with inflammatory bowel disease (IBD) are limited. We evaluated use of IBD medications and association with semen parameters, a proxy of male fertility, and adverse pregnancy outcomes [early pregnancy loss (EPL), preterm birth (PB), congenital malformations (CM)]. Methods We searched Medline, Embase, Scopus, and Web of Science
-
Natural history of patients lost to follow-up after esophageal food impaction Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-20 Fritz Ruprecht Murray, Andrea Kreienbühl, Alex Straumann, Luc Biedermann, Philipp Schreiner
Abstract not available
-
Epidemiology and Healthcare Utilization in Patients with Gastroparesis: A Systematic Review Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-20 Saam Dilmaghani, Ting Zheng, Michael Camilleri
AIM Systematic review of epidemiological data to understand the prevalence, incidence, etiologies, and hospitalizations related to gastroparesis (GP). METHODS Studies of the epidemiology of GP published in all languages, years, and countries from five databases in January 2022 using prespecified search strategies. RESULTS Thirteen studies (data from 1994 – 2019) were included. All but one study (from
-
Uptake of Colorectal Cancer Screening in 45-to-49-year-olds: An Early-Inning View from the Endoscopy Suite Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-20 Thomas F. Imperiale
Abstract not available
-
Patient Preferences for Colorectal Cancer Screening Tests in Light of Lowering the Screening Age to 45 Years Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-20 Katherine E. Makaroff, Jaspreet Shergill, Marie Lauzon, Carine Khalil, Sangeeta C. Ahluwalia, Brennan M.R. Spiegel, Christopher V. Almario
BACKGROUND & AIMS In 2021, the US Preventive Services Task Force lowered the colorectal cancer (CRC) screening age to 45y. We used conjoint analysis—a method that assesses complex decision making—to update our understanding on people’s CRC screening test preferences in the context of new guidelines. METHODS We conducted a conjoint analysis survey among unscreened individuals ≥40yo at average risk for
-
Foaming at the Varix: Sclerotherapy of Esophageal Varices via Intrahepatic Portal Vein Access Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-20 Clara Y. Tow, Julie Sung, Harvey Rosenberg
Abstract not available
-
Artificial intelligence-assisted colonoscopy for colorectal cancer screening: a multicenter randomized controlled trial Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-19 Hong Xu, Raymond S.Y. Tang, Thomas Y.T. Lam, Guijun Zhao, James Y.W. Lau, Yunpeng Liu, Qi Wu, Long Rong, Weiran Xu, Xue Li, Sunny H. Wong, Shuntian Cai, Jing Wang, Guanyi Liu, Tantan Ma, Xiong Liang, Joyce W.Y. Mak, Hongzhi Xu, Joseph J.Y. Sung
Background Artificial intelligence (AI)-assisted colonoscopy improves polyp detection and characterization in colonoscopy. However, data from large scale multicenter randomized controlled trials (RCT) in an asymptomatic population are lacking. Methods This multicenter RCT aimed to compare AI-assisted colonoscopy (AI) to conventional colonoscopy (CC) for adenoma detection in an asymptomatic population
-
Invited Response to “Obesity and Risk of Crohn’s disease half the story” Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-19 Simon S.M. Chan, Hamed Khalili
Abstract not available
-
Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs. Non-Lean NAFLD - A Systematic Review and Meta-Analysis Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-19 Ansel Tang, Cheng Han Ng, Poh Hui Phang, Kai En Chan, Yip Han Chin, Clarissa Elysia Fu, Rebecca Wenling Zeng, Jieling Xiao, Darren Jun Hao Tan, Jingxuan Quek, Wen Hui Lim, Lung Yi Mak, Jiong-wei Wang, Nicholas WS. Chew, Nicholas Syn, Daniel Q. Huang, Mohammad Shadab Siddiqui, Arun Sanyal, Mazen Noureddin
-
Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review with Temporal Analyses Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-19 Michael J. Buie, Joshua Quan BKin, Joseph W. Windsor, Stephanie Coward, Tawnya M. Hansen, James A. King, Paulo G. Kotze, Richard B. Gearry, Siew C. Ng, Joyce WY. Mak, Maria T. Abreu, David T. Rubin, Charles N. Bernstein, Rupa Banerjee, Jesus K. Yamamoto-Furusho, Remo Panaccione, Cynthia H. Seow, Christopher Ma, Maojuan Li
-
Differential relapse patterns after discontinuation of entecavir vs tenofovir disoproxil fumarate in chronic hepatitis B Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-19 Hannah S.J. Choi, Grishma Hirode, Chien-Hung Chen, Tung-Hung Su, Wai-Kay Seto, Stijn Van Hees, Margarita Papatheodoridi, Sabela Lens, Grace L.H. Wong, Sylvia M. Brakenhoff, Rong-Nan Chien, Jordan J. Feld, Milan J. Sonneveld, Henry L.Y. Chan, Xavier Forns, George V. Papatheodoridis, Thomas Vanwolleghem, Man-Fung Yuen, Harry L.A. Janssen
Background and Aims Whether entecavir (ETV) and tenofovir disoproxil fumarate (TDF) differentially affect relapse and outcomes following treatment discontinuation across different patient subpopulations remains unclear. We aimed to compare rates of off-therapy hepatitis B surface antigen (HBsAg) loss, virological and clinical relapse, and retreatment between chronic hepatitis B (CHB) patients who discontinued
-
Comparative effectiveness research to position therapies in ulcerative colitis: how fair are the comparisons? Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-16 Dahham Alsoud, Bram Verstockt, Séverine Vermeire
Abstract not available
-
A Double Clip Slip Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-16 Slim Rita, Safar Carl, Osseis Michael
Abstract not available
-
Colonic actinomycosis mimicking malignant stenosing tumors Clin. Gastroenterol. Hepatol. (IF 13.576) Pub Date : 2022-07-16 Casper Steenholdt, John Gade
Abstract not available
更新日期：2022-08-12
京公网安备 11010802027423号